Medical cannabis: aligning use to evidence‐based medicine approach

During the past decade we have been witnessing a rise in medical cannabis use, yet the evidence for the safety and efficacy of the various cannabinoid compounds is scarce. The State of Israel has always been at the forefront of clinical and translational research in support of Evidence Based Medicin...

Full description

Saved in:
Bibliographic Details
Published in:British journal of clinical pharmacology 2018-11, Vol.84 (11), p.2458-2462
Main Authors: Bar‐Lev Schleider, Lihi, Abuhasira, Ran, Novack, Victor
Format: Article
Language:English
Subjects:
Cannabinoids - adverse effects
Cannabinoids - therapeutic use
Evidence-Based Medicine
Humans
Israel
Medical Marijuana - adverse effects
Medical Marijuana - therapeutic use
Reviews‐themed Issue
Review‐themed Issue
Translational Medical Research - organization & administration
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:During the past decade we have been witnessing a rise in medical cannabis use, yet the evidence for the safety and efficacy of the various cannabinoid compounds is scarce. The State of Israel has always been at the forefront of clinical and translational research in support of Evidence Based Medicine. With respect to cannabis Israel has created a medical and regulatory environment that enables clinical studies with cannabis which may lead to improved Evidence Based use of these compounds. This opinion paper discusses selected studies into the safety and effects of cannabis derived products.
ISSN:0306-5251
1365-2125
DOI:10.1111/bcp.13657